| Open Document File Size: 114,62 KBShare Result on Facebook
City Erlangen / / Company BioMed Central Ltd / Merck / Sharp & Dohme Corporation / / Country Germany / United States / / / Facility Kennedy Institute / Whitehouse Station / / MedicalCondition arthritides / disease / spondylitis / ankylosing spondylitis / arthritis / rheumatic disease / rheumatoid arthritis / rheumatic diseases / tumor necrosis / slow disease / diseases / cartilage injury / stop disease / psoriatic arthritis / low disease / rapidly progressing disease / disorders / / Organization Kennedy Institute in London / / Person Josef S Smolen / Paul P Tak / Joachim R Kalden / Ravinder Maini / Georg Schett / Ferdinand C Breedveld / Paul Emery / Marc Feldman / Bernard Combe / / Position author / / ProvinceOrState New Jersey / / URL http /
SocialTag |
Kalden Arthritis Research & Therapy 2011, 13(Suppl 1):S1 http://arthritis-research.com/content/13/S1/S1 INTRODUCTION Anti-TNF therapy: what have we learned in